Royalty Pharma plc
RPRX
Kedudukan dalam Saham
#860
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$62.20
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$27.69B
Perubahan (1 hari)
-0.09%
Perubahan (1 tahun)
68.82%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
Sejarah harga saham bagi Royalty Pharma plc (RPRX)
Harga penutupan tertinggi: $58.43 pada 2026-10-01
Harga penutupan terendah: $49.50 pada 2020-06-01
Harga penutupan terendah: $49.50 pada 2020-06-01
Sejarah harga saham Royalty Pharma plc dari 2020 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | 27.24% |
| 2025 | 52.96% |
| 2024 | -9.35% |
| 2023 | -31.53% |
| 2022 | 5.51% |
| 2021 | -14.39% |
| 2020 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $46.29 | 37.83% |
SE
|
|
| $171.04 | 23.67% |
FR
|
|
| $116.39 | 58.03% |
US
|
|
| $59.46 | -0.57% |
IT
|
|
| $0.65 | -30.33% |
HK
|
